Search Results
Talaris Presentation at the 2022 Cutting Edge of Transplantation (CEoT) Transplant Summit
Talaris Presentation at the 2022 Tandem Transplantation and Cellular Therapy Meeting
Talaris Therapeutics Presentation at The Transplantation Society (TTS) 2022 Congress
Innovation in Kidney Transplantation and Post-care (Talaris Therapeutics)
Talaris Therapeutics’ Presentation for the Alport Syndrome Foundation Webinar
FREEDOM-1: A New Frontier in Living Donor Kidney Transplant
FCR001, an investigational cell therapy: Harnessing the power of immune tolerance in LDKT for HCP
Discovering a Path to FREEDOM
Ch. 6: FREEDOM-2 Phase 2 Trial with FCR001, Designed to Induce Immune Tolerance in LDKT Recipients